Help Your Patients Take Control of

Chemo-Induced
Nausea & Vomiting

Fast And Effective, Personalized Treatment Of Chemotherapy Induced Nausea And Vomiting

Fast And Effective Relief1

Without Drugs, Without Delay

Can be used before or after symptoms occur.

Self-Care & Control

Convenient & Adjustable

Patients can turn Reletex Reliefband® on and off, or up and down in 5 settings to suit their specific needs.

 

Improved Satisfaction

Better Quality Of Life

92% of patients would recommend Reletex Reliefband® to others undergoing chemotherapy.2

A Patient-Centered Approach To CINV

Patient-centered care, the new transparency of hospital quality of care indices, and competition between facilities has stimulated more interest in improving the patient experience. The manual delivery of anti-emetic medication can be impacted by acute unforeseen demands on nursing resources causing an inherent delivery delay which exacerbates the perception of nausea for the patient. Patients who have control of their own treatment are associated with higher patient satisfaction.2

Help Your Patients

Take Control

of Chemotherapy-Induced Nausea and Vomiting.

A Unique Patient Controlled, Drug-Free Solution To Managing CINV

  • Clinically Proven
    Efficacy Patients using Reletex Reliefband® experienced significantly less nausea, vomiting, and retching for both Acute and Delayed CINV.1
  • Drug Free
    Reletex Reliefband® is free from the unwanted side effects associated with antiemetic drugs and potential drug – drug interactions.
  • Rapid Relief
    Onset of action begins within minutes of activation of Reletex Reliefband®.2
  • Patient-Controlled Therapy
    Patients can easily turn Reletex Reliefband® on /off and adjust the level of stimulation, depending on when they have symptoms.
  • Extended Duration of Therapy
    Reletex Reliefband® can be used for 150 hours (at level 3), covering up to 2 cycles of chemotherapy.
  • Improved Patient Satisfaction and Quality of Life
    In a clinical study, 92% of patients using Reletex Reliefband® would recommend the device to others undergoing chemotherapy.2

INDICATIONS

Reletex Reliefband® is available by prescription for the treatment of nausea as an adjunct to antiemetics in reducing chemotherapy-induced nausea and vomiting. Device is for single patient use.

WARNINGS

Reletex Reliefband®  should only be used on the designated area. Do not use Reletex Reliefband®  when the cause of nausea and vomiting symptoms are undiagnosed. Nausea and vomiting are serious medical conditions; seek medical attention if symptoms continue. Reletex Reliefband®  is not a curative and should always be used under medical supervision. Treatment outcome may vary depending on patient characteristics and use of medications. Reletex Reliefband® should be kept out of reach of children. Pacemaker users- Use the device only as directed on the wrist to prevent possible interference with your pacemaker. Avoid placing the electrodes directly on your chest or near the pacemaker. Consult with your physician if you have other implanted devices. Reletex Reliefband® should not be used above an IV line attached to a patient’s arm. If a patient is using an IV line, Reletex Reliefband® should be placed on the opposite arm.

CAUTION

Federal law (USA) restricts this device to sale by or on the order of a physician or other health care professional licensed in the state in which they practice. Reletex Reliefband® contains metal electrodes. Device is not recommended for use in conjunction with electrocautery or MRI equipment.

SIDE EFFECTS

Isolated cases of skin irritation may occur where the electrodes touch the skin following long term application. Continued use of the device on irritated skin may cause injury. If local skin irritation (redness, swelling, blotches, blisters or itching on the wrist under the device) occurs, discontinue use. If irritation does not disappear within 24 hours, consult your doctor or pharmacist.

References

  1. Treish I, et al. Randomized, double-blind study of the ReliefBand as an adjunct to standard antiemetics in patients receiving moderately-high to highly emetogenic chemotherapy. Support Care Cancer. 2003;11:516-521.
  2. Pearl ML, et al. Transcutaneous electrical nerve stimulation as an adjunct for controlling chemotherapy-induced nausea and vomiting in gynecologic oncology patients. Cancer Nurs. 1999; 22:307-311.